BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37721236)

  • 1. Genotype MTBDRsl version 2 and phenotypic drug resistance detection of
    Radhakrishnan R; Prabuseenivasan S; Hannah S; Vaishanavee V; Senthildevi V; Kannadhasan T; Suchithra R; Rajendran P; Chinnaiyan P; Jayabal L; Frederick A; Shanmugam S
    Int J Mycobacteriol; 2023; 12(3):299-304. PubMed ID: 37721236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlating clinical breakpoint concentration of moxifloxacin with gyrA mutations using the GenoType MTBDRsl assay Version 2.0.
    Sidiq Z; Hanif M; Dwivedi KK; Chopra KK; Khanna A; Vashishat BK
    Indian J Tuberc; 2023 Jul; 70(3):361-365. PubMed ID: 37562913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
    Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct detection of resistance to fluoroquinolones/SLIDs in sputum specimen by GenoType MTBDRsl v.2.0 assay A study from Eastern Uttar Pradesh, India.
    Singh K; Kumari R; Gupta S; Tripathi R; Srivastava A; Shakya V; Gupta A; Anupurba S
    Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):56. PubMed ID: 34446022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains.
    Brossier F; Guindo D; Pham A; Reibel F; Sougakoff W; Veziris N; Aubry A
    J Clin Microbiol; 2016 Jun; 54(6):1573-1580. PubMed ID: 27053671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.
    Brossier F; Veziris N; Aubry A; Jarlier V; Sougakoff W
    J Clin Microbiol; 2010 May; 48(5):1683-9. PubMed ID: 20335420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of MTBDR
    Chandak RJ; Malhotra B; Bhargava S; Goel SK; Verma D; Tiwari J
    Int J Tuberc Lung Dis; 2019 Dec; 23(12):1257-1262. PubMed ID: 31931908
    [No Abstract]   [Full Text] [Related]  

  • 8. GenoType MTBDRsl for detection of second-line drugs and ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates at a high-throughput laboratory.
    Pinhata JMW; Brandao AP; Gallo JF; Oliveira RS; Ferrazoli L
    Diagn Microbiol Infect Dis; 2023 Feb; 105(2):115856. PubMed ID: 36446302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the GenoType MTBDR
    Gardee Y; Dreyer AW; Koornhof HJ; Omar SV; da Silva P; Bhyat Z; Ismail NA
    J Clin Microbiol; 2017 Mar; 55(3):791-800. PubMed ID: 27974543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis.
    Huang WL; Chi TL; Wu MH; Jou R
    J Clin Microbiol; 2011 Jul; 49(7):2502-8. PubMed ID: 21562102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the GenoType MTBDRsl VER 2.0 compared to the phenotypic drug susceptibility testing and whole genome sequencing for the rapid detection of resistance to fluoroquinolone and second-line injectable drugs among rifampicin-resistant Mycobacterium tuberculosis isolates.
    Kardan-Yamchi J; Amini S; Hamzelou G; Rahimi Foroushani A; Ghodousi A; Cirillo DM; Feizabadi MM
    Arch Microbiol; 2021 Sep; 203(7):3989-3996. PubMed ID: 34032874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of GenoType MTBDRsl for testing resistance of Mycobacterium tuberculosis isolates to fluoroquinlone, aminoglycoside, and ethambutol].
    Chikamatsu K; Aono A; Yamada H; Mitarai S
    Kekkaku; 2012 Oct; 87(10):641-7. PubMed ID: 23214120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh.
    Rahman SMM; Nasrin R; Rahman A; Ahmed S; Khatun R; Uddin MKM; Rahman MM; Banu S
    PLoS One; 2021; 16(12):e0261329. PubMed ID: 34914803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
    Xie YL; Chakravorty S; Armstrong DT; Hall SL; Via LE; Song T; Yuan X; Mo X; Zhu H; Xu P; Gao Q; Lee M; Lee J; Smith LE; Chen RY; Joh JS; Cho Y; Liu X; Ruan X; Liang L; Dharan N; Cho SN; Barry CE; Ellner JJ; Dorman SE; Alland D
    N Engl J Med; 2017 Sep; 377(11):1043-1054. PubMed ID: 28902596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of GenoType MTBDR
    Yadav RN; Bhalla M; Kumar G; Sah GC; Dewan RK; Singhal R
    Int J Mycobacteriol; 2022; 11(2):183-189. PubMed ID: 35775551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
    Ogari CO; Nyamache AK; Nonoh J; Amukoye E
    BMC Infect Dis; 2019 Mar; 19(1):279. PubMed ID: 30909867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments.
    Ajbani K; Nikam C; Kazi M; Gray C; Boehme C; Balan K; Shetty A; Rodrigues C
    PLoS One; 2012; 7(11):e49433. PubMed ID: 23166667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-center evaluation of GenoType MTBDRsl line probe assay for rapid detection of pre-XDR and XDR Mycobacterium tuberculosis in China.
    Gao Y; Zhang Z; Deng J; Mansjö M; Ning Z; Li Y; Li X; Hu Y; Hoffner S; Xu B
    J Infect; 2018 Oct; 77(4):328-334. PubMed ID: 29969597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-actionable Results, Accuracy, and Effect of First- and Second-line Line Probe Assays for Diagnosing Drug-Resistant Tuberculosis, Including on Smear-Negative Specimens, in a High-Volume Laboratory.
    Pillay S; de Vos M; Derendinger B; Streicher EM; Dolby T; Scott LA; Steinhobel AD; Warren RM; Theron G
    Clin Infect Dis; 2023 Feb; 76(3):e920-e929. PubMed ID: 35788278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of the GenoType MTBDRsl assay for the detection second-line anti-tuberculosis drug resistance.
    Lee YS; Lee BY; Jo KW; Shim TS
    J Infect Chemother; 2017 Dec; 23(12):820-825. PubMed ID: 29066216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.